Congress' Misguided Plan to Ban QALYs

Leah Z Rand; Adam Raymakers; Benjamin N Rome

doi:10.1001/jama.2023.8695

Congress' Misguided Plan to Ban QALYs

JAMA. 2023 Jun 27;329(24):2125-2126. doi: 10.1001/jama.2023.8695.

Authors

Leah Z Rand^{1

2}, Adam Raymakers^{1

3}, Benjamin N Rome^{1

3}

Affiliations

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Harvard Medical School Center for Bioethics, Boston, Massachusetts.
³ Harvard Medical School, Boston, Massachusetts.

PMID: 37289466
DOI: 10.1001/jama.2023.8695

No abstract available

Plain language summary

This Viewpoint discusses the flawed assumptions and potential negative impacts of a proposed federal bill that would ban government health care programs from using the quality-adjusted life-year (QALY) and “similar measures” when determining insurance coverage or negotiating prices.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Federal Government*
Legislation as Topic
Quality-Adjusted Life Years*
United States